wen zhai

..............page:4-5

Expert opinion on the clinical use of biphasic insulin aspart 50
mu yi ming ;, su ben li ;, jiao kai ;, pu lian shan ;, li qing ju ;

..............page:6-8

Investigation the clinical application ofinsulin aspart 30 from the newer concepts
li quan min ;

..............page:9-12

Biphasic insulin aspart 30: the newchoice of postmeal glucose in diabetes
zuo guang xia ;

..............page:13-15,23

Comprehensively consideration andintegrated management-the application of dipeptidy peptidase-4 inhitors in type 2 diabetes
wang you min ;

..............page:16-19,27

Role of different dipeptidy peptidase-4 inhitors in specific populations with type 2 diabetes
gu wei jun ;

..............page:20-23

The special structure and effect of non-peptidomimetic different dipeptidy peptidase-4 inhitors
ji li wei ;

..............page:24-27

Basal insulin combined with dipeptidylpeptidase-4 inhibitors
kang yao jie ;, wang zuo ;

..............page:28-32,48

Insulin therapy in pregnancy withdiabetes mellitus
zhang zuo ;, xue yao ming ;

..............page:33-37,48

Gestational weight gain on thepregnancy outcome of gestational diabetes mellitus
fu jun bo ;, cong li ;

..............page:38-41

Chinese expert consensus statement on postprandialhyperglycemia in type 2 diabetes mellitus
zhong guo xing tang niao bing huan zhe can hou gao xue tang guan li zhuan jia gong shi bian xie zu ;

..............page:42-48